Original language | English |
---|---|
Article number | 101528 |
Journal | Translational Oncology |
Volume | 25 |
DOIs |
|
Publication status | Published - Nov 2022 |
Authors’ reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
Fredrik H. Schjesvold*, Nicolaas A. Bakker, Pieter Sonneveld
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
3
Citations
(Scopus)
61
Downloads
(Pure)